BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Toll-like receptor 9 (TLR9)

April 28, 2016 7:00 AM UTC

Patient sample and mouse studies suggest TLR9 antagonists could help treat insulin resistance. In healthy volunteers without overt metabolic disease, high plasma levels of single-stranded DNA, a TLR9 ...